» Authors » Michael Augenbraun

Michael Augenbraun

Explore the profile of Michael Augenbraun including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 1095
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Bambha K, Pierce C, Cox C, French A, Tien P, Sharp G, et al.
AIDS . 2011 Dec; 26(5):599-607. PMID: 22156972
Objective: Co-infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality in HIV-infected individuals. However, predictors of mortality are poorly defined and most studies have focused...
32.
Hoffman S, Higgins J, Beckford-Jarrett S, Augenbraun M, Bylander K, Mantell J, et al.
Cult Health Sex . 2011 Apr; 13(5):513-28. PMID: 21452091
To generate insights into how migration shapes sexual risk and protection, we interviewed 36 female and 20 male West Indian immigrants attending a public sexually transmitted disease clinic in Brooklyn,...
33.
Howard A, Hoover D, Anastos K, Wu X, Shi Q, Strickler H, et al.
J Acquir Immune Defic Syndr . 2010 Mar; 54(2):152-9. PMID: 20190642
Background: Opiate use is common in HIV-infected and hepatitis C virus (HCV)-infected individuals, however, its contribution to the risk of diabetes mellitus is not well understood. Methods: Prospective study of...
34.
Kovacs A, Karim R, Mack W, Xu J, Chen Z, Operskalski E, et al.
J Infect Dis . 2010 Feb; 201(6):823-34. PMID: 20151840
Background: Because activation of T cells is associated with human immunodeficiency virus (HIV) pathogenesis, CD4 and CD8 activation levels in patients coinfected with HIV and hepatitis C virus (HCV) may...
35.
Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, et al.
AIDS Patient Care STDS . 2009 Nov; 23(11):915-23. PMID: 19877800
Although the primary mode of hepatitis C virus (HCV) transmission is exposure to blood products or injection drug use (IDU), studies have found varying independent risk factors for HCV infection...
36.
Wallace D, Arquilla B, Heffernan R, Kramer M, Anderson T, Bernstein D, et al.
Am J Emerg Med . 2009 Jun; 27(4):419-23. PMID: 19555611
Objectives: We describe a field simulation that was conducted using volunteers to assess the ability of 3 hospitals in a network to manage a large influx of patients with a...
37.
Berwald N, Zehtabchi S, Cheng S, Augenbraun M, Abu-Lawi K, McLaughlin T, et al.
Am J Emerg Med . 2009 Jun; 27(5):563-9. PMID: 19497462
Background: Early diagnosis of sexually transmitted infections (STI) such as Chlamydia trachomatis (CT) and Neisseria gonorrhoea (NG) is crucial in reducing complications. Vaginal bleeding (VB) has been suggested as a...
38.
French A, Gawel S, Hershow R, Benning L, Hessol N, Levine A, et al.
J Acquir Immune Defic Syndr . 2009 Jun; 51(4):399-406. PMID: 19487953
Background: To assess trends in mortality and cause of death for women with HIV, we studied deaths over a 10-year period among participants in the Women's Interagency HIV Study, a...
39.
French A, Lin M, Evans C, Benning L, Glesby M, Young M, et al.
Clin Infect Dis . 2009 Jun; 49(1):148-54. PMID: 19480573
Background: Isolated antibody to hepatitis B core antigen (anti-HBc) is a common serologic finding in persons infected with human immunodeficiency virus (HIV), but the outcome and clinical significance are uncertain....
40.
Tsui J, Vittinghoff E, Anastos K, Augenbraun M, Young M, Nowicki M, et al.
Am J Kidney Dis . 2009 Apr; 54(1):43-50. PMID: 19394735
Background: How coinfection with hepatitis C virus (HCV) impacts on the trajectory of kidney function in human immunodeficiency virus (HIV)-infected patients is unclear. This study examined the effect of HCV...